- Biopharma News
German pharma companies are meeting the corona "stress test"7 Apr 2020
The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications.
Amidst the coronavirus pandemic people in many countries worry whether too many crucial elements in their healthcare systems have been outsourced, in particular to China. In an interview with Germany Trade & Invest, Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies (VfA), has said he believes that's not a concern for German pharma.
"Germany is one of the world's strongest production locations where innovative, patented medications are concerned," Steutel explained. "Even amidst the stress test of the corona pandemic, Germany has remained capable of delivering and has exported significantly more patented medical products to China than it has imported from that country."
Death rates from Sars-CoV-2, the respiratory disease caused by the coronavirus, are far lower in Germany than almost everywhere else in the world. The VfA says German expertise is hard at work in all areas of the fight against corona-related ailments.
"There are around 60 companies and institutes working at top speed on vaccines," said Steutel. "Several dozens of existing medications are being tested to see if they can help corona patients. And a series of new medications are being developed, mostly on the basis of antibodies. German companies and institutes are part of all three efforts."
Steutel added that Germany's 44 researched-based pharmaceutical companies were cooperating internationally and with biotech firms in the search for corona medications.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation